Subcortical ischemic vascular disease: Roles of oligodendrocyte function in experimental models of subcortical white-matter injury

Journal of Cerebral Blood Flow and Metabolism

Volumn 36, Issue 1, 2016, Pages 187-198

  Shindo, Akihiro ^a,b   Liang, Anna C ^a   Maki, Takakuni ^a   Miyamoto, Nobukazu ^a   Tomimoto, Hidekazu ^b   Lo, Eng H ^a   Arai, Ken ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Neurovascular unit; oligodendrocyte; subcortical ischemic vascular disease

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; CYTOKINE; EXCITATORY AMINO ACID; MYELIN; NEUROTROPHIC FACTOR; VASOCONSTRICTOR AGENT;

ASTROCYTE; BRAIN ISCHEMIA; CADASIL; CELL DAMAGE; CELL INTERACTION; CELL LINEAGE; COGNITION; HUMAN; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE FIBER; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; PERICYTE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; WHITE MATTER; WHITE MATTER INJURY; ANIMAL; CELL COMMUNICATION; CELL PROLIFERATION; COMPLICATION; DEMENTIA, VASCULAR; DISEASE MODEL; NERVE CELL; PATHOLOGY; STROKE, LACUNAR;

ANIMALS; BRAIN ISCHEMIA; CELL COMMUNICATION; CELL PROLIFERATION; DEMENTIA, VASCULAR; DISEASE MODELS, ANIMAL; HUMANS; NEURONS; OLIGODENDROGLIA; STROKE, LACUNAR; WHITE MATTER;

EID: 84951569358     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2015.80     Document Type: Review

References (112)

1. Candelario-Jalil E, Thompson J, Taheri S, Grossetete M, Adair JC, Edmonds E, et al. Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment. Stroke 2011; 42: 1345-1350
2. Rosenberg GA, Bjerke M and Wallin A. Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment. Stroke 2014; 45: 1531-1538
3. Baumann N and Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 2001; 81: 871-927
4. Lo EH, Dalkara T and Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003; 4: 399-415
5. del Zoppo GJ. Inflammation and the neurovascular unit in the setting of focal cerebral ischemia. Neuroscience 2009; 158: 972-982
6. Hawkins BT and Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005; 57: 173-185
7. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 2004; 5: 347-360
8. Lo EH, Broderick JP and Moskowitz MA. tPA and proteolysis in the neurovascular unit. Stroke 2004; 35: 354-356
9. Zacchigna S, Lambrechts D and Carmeliet P. Neurovascular signalling defects in neurodegeneration. Nat Rev Neurosci 2008; 9: 169-181
10. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008; 57: 178-201
11. Wilkins A, Majed H, Layfield R, Compston A and Chandran S. Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J Neurosci 2003; 23: 4967-4974
12. Seo JH, Maki T, Maeda M, Miyamoto N, Liang AC, Hayakawa K, et al. Oligodendrocyte precursor cells support blood-brain barrier integrity via TGF-beta signaling. PLoS One 2014; 9: e103174
13. Seo JH, Miyamoto N, Hayakawa K, Pham LD, Maki T, Ayata C, et al. Oligodendrocyte precursors induce early blood-brain barrier opening after white matter injury. J Clin Invest 2013; 123: 782-786
14. Miyamoto N, Pham LD, Hayakawa K, Matsuzaki T, Seo JH, Magnain C, et al. Age-related decline in oligodendrogenesis retards white matter repair in mice. Stroke 2013; 44: 2573-2578
15. Rosenzweig S and Carmichael ST. Age-dependent exacerbation of white matter stroke outcomes: a role for oxidative damage and inflammatory mediators. Stroke 2013; 44: 2579-2586
16. Arai K and Lo EH. Experimental models for analysis of oligodendrocyte pathophysiology in stroke. Exp Transl Stroke Med 2009; 1: 6
17. Butts BD, Houde C and Mehmet H. Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease. Cell Death Differ 2008; 15: 1178-1186
18. Matute C. Glutamate and ATP signalling in white matter pathology. J Anat 2011; 219: 53-64
19. Arai K and Lo EH. Oligovascular signaling in white matter stroke. Biol Pharm Bull 2009; 32: 1639-1644
20. Wakita H, Tomimoto H, Akiguchi I and Kimura J. Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: an immunohistochemical study. Acta Neuropathol 1994; 87: 484-492
21. Farkas E, Donka G, de Vos RA, Mihaly A, Bari F and Luiten PG. Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain. Acta Neuropathol 2004; 108: 57-64
22. Wakita H, Tomimoto H, Akiguchi I, Matsuo A, Lin JX, Ihara M, et al. Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res 2002; 924: 63-70
23. Tomimoto H, Ihara M, Wakita H, Ohtani R, Lin JX, Akiguchi I, et al. Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat. Acta Neuropathol 2003; 106: 527-534
24. Chida Y, Kokubo Y, Sato S, Kuge A, Takemura S, Kondo R, et al. The alterations of oligodendrocyte, myelin in corpus callosum, and cognitive dysfunction following chronic cerebral ischemia in rats. Brain Res 2011; 1414: 22-31
25. Sood R, Yang Y, Taheri S, Candelario-Jalil E, Estrada EY, Walker EJ, et al. Increased apparent diffusion coefficients on MRI linked with matrix metalloproteinases and edema in white matter after bilateral carotid artery occlusion in rats. J Cereb Blood Flow Metab 2009; 29: 308-316
26. Jalal FY, Yang Y, Thompson J, Lopez AC and Rosenberg GA. Myelin loss associated with neuroinflammation in hypertensive rats. Stroke 2012; 43: 1115-1122
27. Shibata M, Ohtani R, Ihara M and Tomimoto H. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 2004; 35: 2598-2603
28. Miyamoto N, Pham LD, Maki T, Liang AC and Arai K. A radical scavenger edaravone inhibits matrix metalloproteinase-9 upregulation and blood-brain barrier breakdown in a mouse model of prolonged cerebral hypoperfusion. Neurosci Lett 2014; 573: 40-45
29. Miyamoto N, Tanaka R, Shimura H, Watanabe T, Mori H, Onodera M, et al. Phosphodiesterase III inhibition promotes differentiation and survival of oligodendrocyte progenitors and enhances regeneration of ischemic white matter lesions in the adult mammalian brain. J Cereb Blood Flow Metab 2010; 30: 299-310
30. Shibata M, Yamasaki N, Miyakawa T, Kalaria RN, Fujita Y, Ohtani R, et al. Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke 2007; 38: 2826-2832
31. Maki T, Ihara M, Fujita Y, Nambu T, Miyashita K, Yamada M, et al. Angiogenic and vasoprotective effects of adrenomedullin on prevention of cognitive decline after chronic cerebral hypoperfusion in mice. Stroke 2011; 42: 1122-1128
32. Miyamoto N, Maki T, Pham LD, Hayakawa K, Seo JH, Mandeville ET, et al. Oxidative stress interferes with white matter renewal after prolonged cerebral hypoperfusion in mice. Stroke 2013; 44: 3516-3521
33. Kitamura A, Fujita Y, Oishi N, Kalaria RN, Washida K, Maki T, et al. Selective white matter abnormalities in a novel rat model of vascular dementia. Neurobiol Aging 2012; 33: e25-e35
34. Hattori Y, Kitamura A, Nagatsuka K and Ihara M. A novel mouse model of ischemic carotid artery disease. PloS one 2014; 9: e100257
35. Frost SB, Barbay S, Mumert ML, Stowe AM and Nudo RJ. An animal model of capsular infarct: endothelin-1 injections in the rat. Behav Brain Res 2006; 169: 206-211
36. Sozmen EG, Kolekar A, Havton LA and Carmichael ST. A white matter stroke model in the mouse: axonal damage, progenitor responses and MRI correlates. J Neurosci Methods 2009; 180: 261-272
37. Sozmen EG, Hinman JD and Carmichael ST. Models that matter: white matter stroke models. Neurotherapeutics 2012; 9: 349-358
38. Hinman JD, Rasband MN and Carmichael ST. Remodeling of the axon initial segment after focal cortical and white matter stroke. Stroke 2013; 44: 182-189
39. Ramos-Cejudo J, Gutierrez-Fernandez M, Otero-Ortega L, Rodriguez-Frutos B, Fuentes B, Vallejo-Cremades MT, et al. Brain-derived neurotrophic factor administration mediated oligodendrocyte differentiation and myelin formation in subcortical ischemic stroke. Stroke 2015; 46: 221-228
40. Joutel A and Faraci FM. Cerebral small vessel disease: insights and opportunities from mouse models of collagen IV-related small vessel disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke 2014; 45: 1215-1221
41. Ayata C. CADASIL: experimental insights from animal models. Stroke 2010; 41: S129-S134
42. Craggs LJ, Fenwick R, Oakley AE, Ihara M and Kalaria RN. Immunolocalisation of PDGFRbeta and pericytes in CADASIL. Neuropathol Appl Neurobiol 2014; doi:10.1111/nan.12188
43. Cognat E, Cleophax S, Domenga-Denier V and Joutel A. Early white matter changes in CADASIL: evidence of segmental intramyelinic oedema in a pre-clinical mouse model. Acta Neuropathol Commun 2014; 2: 49
44. Zaucker A, Mercurio S, Sternheim N, Talbot WS and Marlow FL. notch3 is essential for oligodendrocyte development and vascular integrity in zebrafish. Dis Model Mech 2013; 6: 1246-1259
45. Pantoni L, Garcia JH and Gutierrez JA. Cerebral white matter is highly vulnerable to ischemia. Stroke 1996; 27: 1641-1646, discussion 1647
46. Mandai K, Matsumoto M, Kitagawa K, Matsushita K, Ohtsuki T, Mabuchi T, et al. Ischemic damage and subsequent proliferation of oligodendrocytes in focal cerebral ischemia. Neuroscience 1997; 77: 849-861
47. McIver SR, Muccigrosso M, Gonzales ER, Lee JM, Roberts MS, Sands MS, et al. Oligodendrocyte degeneration and recovery after focal cerebral ischemia. Neuroscience 2010; 169: 1364-1375
48. Yang Y, Jalal FY, Thompson JF, Walker EJ, Candelario-Jalil E, Li L, et al. Tissue inhibitor of metalloproteinases-3 mediates the death of immature oligodendrocytes via TNF-alpha/TACE in focal cerebral ischemia in mice. J Neuroinflammation 2011; 8: 108
49. Ohta K, Iwai M, Sato K, Omori N, Nagano I, Shoji M, et al. Dissociative increase of oligodendrocyte progenitor cells between young and aged rats after transient cerebral ischemia. Acta Neurochir 2003; 86: 187-189
50. Wang P, Tian WW, Song J, Guan YF and Miao CY. Deficiency of NG2 cells contributes to the susceptibility of stroke-prone spontaneously hypertensive rats. CNS Neurosci Ther 2011; 17: 327-332
51. Jing L, He Q, Zhang JZ and Li PA. Temporal profile of astrocytes and changes of oligodendrocyte-based myelin following middle cerebral artery occlusion in diabetic and non-diabetic rats. Int J Biol Sci 2013; 9: 190-199
52. Emery B. Regulation of oligodendrocyte differentiation and myelination. Science 2010; 330: 779-782
53. Franklin RJ and Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 2008; 9: 839-855
54. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 1998; 280: 1610-1613
55. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, et al. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 2003; 33: 366-374
56. Funfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 2012; 485: 517-521
57. Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 2012; 487: 443-448
58. Sakry D, Neitz A, Singh J, Frischknecht R, Marongiu D, Biname F, et al. Oligodendrocyte precursor cells modulate the neuronal network by activity-dependent ectodomain cleavage of glial NG2. PLoS Biol 2014; 12: e1001993
59. Cheatwood JL, Emerick AJ, Schwab ME and Kartje GL. Nogo-A expression after focal ischemic stroke in the adult rat. Stroke 2008; 39: 2091-2098
60. Schmandke A, Schmandke A and Schwab ME. Nogo-A: multiple roles in CNS development, maintenance, and disease. Neuroscientist 2014; 20: 372-386
61. Rodriguez JP, Coulter M, Miotke J, Meyer RL and Takemaru K. Abrogation of beta-catenin signaling in oligodendrocyte precursor cells reduces glial scarring and promotes axon regeneration after CNS injury. J Neurosci 2014; 34: 10285-10297
62. Mitew S, Hay CM, Peckham H, Xiao J, Koenning Mand Emery B. Mechanisms regulating the development of oligodendrocytes and central nervous system myelin. Neuroscience 2014; 276: 29-47
63. Brinkmann BG, Agarwal A, Sereda MW, Garratt AN, Muller T, Wende H, et al. Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron 2008; 59: 581-595
64. Hill RA, Patel KD, Goncalves CM and Grutzendler J. Modulation of oligodendrocyte generation during a critical temporal window after NG2 cell division. Nat Neurosci 2014; 17: 1518-1527
65. Etxeberria A, Mangin JM, Aguirre A, Gallo V and Adult-born SVZ. progenitors receive transient synapses during remyelination in corpus callosum. Nat Neurosci 2010; 13: 287-289
66. Wang S, Sdrulla AD, diSibio G, Bush G, Nofziger D, Hicks C, et al. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 1998; 21: 63-75
67. Charles P, Hernandez MP, Stankoff B, Aigrot MS, Colin C, Rougon G, et al. Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule. Proc Natl Acad Sci USA 2000; 97: 7585-7590
68. Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, et al. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 2005; 8: 745-751
69. Ohab JJ, Fleming S, Blesch A and Carmichael ST. A neurovascular niche for neurogenesis after stroke. J Neurosci 2006; 26: 13007-13016
70. Kokovay E, Goderie S, Wang Y, Lotz S, Lin G, Sun Y, et al. Adult SVZ lineage cells home to and leave the vascular niche via differential responses to SDF1/CXCR4 signaling. Cell Stem Cell 2010; 7: 163-173
71. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H, et al. Administration of CD34 cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004; 114: 330-338
72. Thored P, Wood J, Arvidsson A, Cammenga J, Kokaia Z and Lindvall O. Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke. Stroke 2007; 38: 3032-3039
73. Miyamoto N, Pham LD, Seo JH, Kim KW, Lo EH and Arai K. Crosstalk between cerebral endothelium and oligodendrocyte. Cell Mol Life Sci 2014; 71: 1055-1066
74. Arai K and Lo EH. An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells. J Neurosci 2009; 29: 4351-4355
75. Arai K, Lok J, Guo S, Hayakawa K, Xing C and Lo E. Cellular mechanisms of neurovascular damage and repair after stroke. J Child Neurol 2011; 26: 1193-1201
76. Hayakawa K, Seo J, Pham L-D, Miyamoto N, Som A, Guo S, et al. Cerebral endothelial derived vascular endothelial growth factor promotes the migration but not the proliferation of oligodendrocyte precursor cells in vitro. Neurosci Lett 2012; 513: 42-48
77. Hayakawa K, Pham L-D, Katusic Z, Arai K and Lo E. Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery. Proc Natl Acad Sci USA 2012; 109: 7505-7515
78. Arai K and Lo EH. Astrocytes protect oligodendrocyte precursor cells via MEK/ERK and PI3K/Akt signaling. J Neurosci Res 2010; 88: 758-763
79. Kato S, Aoyama M, Kakita H, Hida H, Kato I, Ito T, et al. Endogenous erythropoietin from astrocyte protects the oligodendrocyte precursor cell against hypoxic and reoxygenation injury. J Neurosci Res 2011; 89: 1566-1574
80. Orthmann-Murphy JL, Abrams CK and Scherer SS. Gap junctions couple astrocytes and oligodendrocytes. J Mol Neurosci 2008; 35: 101-116
81. Butt AM, Ibrahim M, Ruge FM and Berry M. Biochemical subtypes of oligodendrocyte in the anterior medullary velum of the rat as revealed by the monoclonal antibody Rip. Glia 1995; 14: 185-197
82. Corley SM, Ladiwala U, Besson A and Yong VW. Astrocytes attenuate oligodendrocyte death in vitro through an alpha(6) integrin-laminin-dependent mechanism. Glia 2001; 36: 281-294
83. Fok-Seang J, DiProspero NA, Meiners S, Muir E and Fawcett JW. Cytokine-induced changes in the ability of astrocytes to support migration of oligodendrocyte precursors and axon growth. Eur J Neurosci 1998; 10: 2400-2415
84. Fulmer CG, VonDran MW, Stillman AA, Huang Y, Hempstead BL and Dreyfus CF. Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination. J Neurosci 2014; 34: 8186-8196
85. Olah M, Amor S, Brouwer N, Vinet J, Eggen B, Biber K, et al. Identification of a microglia phenotype supportive of remyelination. Glia 2012; 60: 306-321
86. Hughes EG, Kang SH, Fukaya M and Bergles DE. Oligodendrocyte progenitors balance growth with selfrepulsion to achieve homeostasis in the adult brain. Nat Neurosci 2013; 16: 668-676
87. Butovsky O, Landa G, Kunis G, Ziv Y, Avidan H, Greenberg N, et al. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Invest 2006; 116: 905-915
88. Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 2013; 16: 1211-1218
89. Oka A, Belliveau MJ, Rosenberg PA and Volpe JJ. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J Neurosci 1993; 13: 1441-1453
90. Buntinx M, Gielen E, Van Hummelen P, Raus J, Ameloot M, Steels P, et al. Cytokine-induced cell death in human oligodendroglial cell lines. II: Alterations in gene expression induced by interferon-gamma and tumor necrosis factor-alpha. J Neurosci Res 2004; 76: 846-861
91. Ferent J, Zimmer C, Durbec P, Ruat M and Traiffort E. Sonic Hedgehog signaling is a positive oligodendrocyte regulator during demyelination. J Neurosci 2013; 33: 1759-1772
92. Chung AY, Kim S, Kim E, Kim D, Jeong I, Cha YR, et al. Indian hedgehog B function is required for the specification of oligodendrocyte progenitor cells in the zebrafish CNS. J Neurosci 2013; 33: 1728-1733
93. Ortega F, Gascon S, Masserdotti G, Deshpande A, Simon C, Fischer J, et al. Oligodendrogliogenic and neurogenic adult subependymal zone neural stem cells constitute distinct lineages and exhibit differential responsiveness to Wnt signalling. Nat Cell Biol 2013; 15: 602-613
94. Sher F, Rossler R, Brouwer N, Balasubramaniyan V, Boddeke E and Copray S. Differentiation of neural stem cells into oligodendrocytes: involvement of the polycomb group protein Ezh2. Stem Cells 2008; 26: 2875-2883
95. Soundarapandian MM, Selvaraj V, Lo UG, Golub MS, Feldman DH, Pleasure DE, et al. Zfp488 promotes oligodendrocyte differentiation of neural progenitor cells in adult mice after demyelination. Sci Rep 2011; 1: 2
96. Murtie JC, Zhou YX, Le TQ, Vana AC and Armstrong RC. PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol Dis 2005; 19: 171-182
97. Aparicio E, Mathieu P, Pereira Luppi M, Almeira Gubiani MF and Adamo AM. The Notch signaling pathway: its role in focal CNS demyelination and apotransferrin-induced remyelination. J Neurochem 2013; 127: 819-836
98. Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, et al. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 2002; 109: 75-86
99. Nakatani H, Martin E, Hassani H, Clavairoly A, Maire CL, Viadieu A, et al. Ascl1/Mash1 promotes brain oligodendrogenesis during myelination and remyelination. J Neurosci 2013; 33: 9752-9768
100. Liu A, Han YR, Li J, Sun D, Ouyang M, Plummer MR, et al. The glial or neuronal fate choice of oligodendrocyte progenitors is modulated by their ability to acquire an epigenetic memory. J Neurosci 2007; 27: 7339-7343
101. Wang SZ, Dulin J, Wu H, Hurlock E, Lee SE, Jansson K, et al. An oligodendrocyte-specific zinc-finger transcription regulator cooperates with Olig2 to promote oligodendrocyte differentiation. Development 2006; 133: 3389-3398
102. Tanaka T, Murakami K, Bando Y and Yoshida S. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizoneinduced demyelination. J Neurochem 2013; 127: 259-270
103. Dugas JC, Cuellar TL, Scholze A, Ason B, Ibrahim A, Emery B, et al. Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination. Neuron 2010; 65: 597-611
104. Zhao X, He X, Han X, Yu Y, Ye F, Chen Y, et al. MicroRNA-mediated control of oligodendrocyte differentiation. Neuron 2010; 65: 612-626
105. Girard C, Bemelmans AP, Dufour N, Mallet J, Bachelin C, Nait-Oumesmar B, et al. Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord. J Neurosci 2005; 25: 7924-7933
106. Xiao J, Wong AW, Willingham MM, van den Buuse M, Kilpatrick TJ and Murray SS. Brain-derived neurotrophic factor promotes central nervous system myelination via a direct effect upon oligodendrocytes. Neurosignals 2010; 18: 186-202
107. Woodruff RH, Fruttiger M, Richardson WD and Franklin RJ. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol Cell Neurosci 2004; 25: 252-262
108. Armstrong RC, Le TQ, Frost EE, Borke RC and Vana AC. Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J Neurosci 2002; 22: 8574-8585
109. Biname F, Sakry D, Dimou L, Jolivel V and Trotter J. NG2 regulates directional migration of oligodendrocyte precursor cells via Rho GTPases and polarity complex proteins. J Neurosci 2013; 33: 10858-10874
110. Barres BA, Burne JF, Holtmann B, Thoenen H, Sendtner M and Raff MC. Ciliary neurotrophic factor enhances the rate of oligodendrocyte generation. Mol Cell Neurosci 1996; 8: 146-156
111. Mason JL, Jones JJ, Taniike M, Morell P, Suzuki K and Matsushima GK. Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J Neurosci Res 2000; 61: 251-262
112. Mason JL, Suzuki K, Chaplin DD and Matsushima GK. Interleukin-1beta promotes repair of the CNS. J Neurosci 2001; 21: 7046-7052.